Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease
Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S
Molecular Neurodegeneration · 2022
Key finding
There is strong increasing evidence supporting a role for the gut microbiome in the pathogenesis of Alzheimer's disease, including effects on synaptic dysfunction and neuroinflammation, which contribute to cognitive decline.
Auto-extracted · verification pendingHow we verify
- Condition
- Alzheimer's Disease
- Stimulation
- iVNS
- Evidence tier
- Narrative / Scoping Review
- Participants
- —
Share this study
Download the citation card as a PNG, or copy a link to this page.
Cite this study
Bairamian, D., Sha, S., Rolhion, N., Sokol, H., Dorothée, G., Lemere, C. A., & Krantic, S. (2022). Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease. Molecular Neurodegeneration, 17(1). https://doi.org/10.1186/s13024-022-00522-2
Related studies in Alzheimer's Disease
Advances in VNS efficiency and mechanisms of action on cognitive functions
Wang et al. · Frontiers in physiology · 2024 · Systematic Review / Meta-Analysis
Evaluating phasic transcutaneous vagus nerve stimulation (taVNS) with pupil dilation: the importance of stimulation intensity and sensory perception
Ludwig et al. · Scientific reports · 2024 · Controlled Clinical Trial
Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus
Shen et al. · The international journal of neuropsychopharmacology · 2012 · Controlled Clinical Trial
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year
Merrill et al. · The Journal of clinical psychiatry · 2006 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.